U.S. health information • Prescription medicines require a valid prescription and licensed pharmacy • Emergency? Call 911
HomeMedicine information
Opioid combination pain medicine Prescription required

Percocet E712

★★★★★ 5.0/5 (44 ratings visible in supplied image)

Percocet E712 is described in the reference guide as an immediate-release combination containing oxycodone hydrochloride 10mg and acetaminophen 325mg. The E712 imprint is associated with the 10/325 strength of Endocet; a tablet marking does not independently verify authenticity.

Reference price per pack $420.00 $496.00
60 pieces per pack • Strength shown: 10 mg

90 pieces: $549.00 per pack · 180 pieces: $1,049.00 per pack

Select pack size and quantity

Choose at least one pack. Buy Now adds the selected packs and opens the cart; it does not take payment.

View Cart
Prescription verification required

Submitting a cart request is not a confirmed purchase. The existing request flow does not verify a prescription automatically. Prescription, eligibility and applicable legal checks must be completed by authorized staff before accepting an order, collecting payment or dispensing medicine.

Product description and identification

This combination contains oxycodone, an opioid analgesic, and acetaminophen (also called paracetamol), a non-opioid pain reliever and fever reducer. The reference guide says E712 is the imprint on Endo Pharmaceuticals’ Endocet 10mg/325mg strength, although the product is commonly described as Percocet.

The guide describes the E712 tablet as yellow and oval. Colour and imprint are reference characteristics only and cannot prove that a tablet is genuine.

Clinical context described in the reference

Official labeling described by the guide covers acute pain severe enough to require an opioid when alternative treatments are insufficient. The guide notes that combination opioid medicines are generally intended for short courses because opioid and acetaminophen risks accumulate with exposure.

Important safety warnings

Oxycodone can cause life-threatening respiratory depression, addiction, abuse and misuse. Combining it with benzodiazepines or other central nervous system depressants can cause profound sedation, coma and death. Regular opioid use during pregnancy can cause neonatal opioid withdrawal.

Acetaminophen adds a separate risk of severe liver injury, especially when multiple acetaminophen-containing products are combined, the total amount is excessive, or alcohol is involved. Early poisoning may have few symptoms; suspected excess requires urgent medical assessment.

Possible side effects

The reference lists nausea, constipation, sleepiness, dizziness, lightheadedness, vomiting, dry mouth and headache. Serious warning signs include slow or difficult breathing, unresponsiveness, upper-abdominal pain, yellowing of the skin or eyes, dark urine, unusual bruising, and severe rash or blistering.

Drug, alcohol and food interactions

Alcohol can increase sedation and breathing depression and can worsen acetaminophen-related liver toxicity. Benzodiazepines, sleeping medicines, other opioids, carisoprodol and sedating antihistamines can deepen sedation.

The guide also notes interactions involving CYP3A4 inhibitors, enzyme-inducing medicines, warfarin and serotonergic antidepressants. A pharmacist should review the complete medication list.

Pregnancy, breastfeeding and other precautions

Regular opioid exposure during pregnancy may cause neonatal opioid withdrawal. Both ingredients pass into breast milk; the guide reports infant sedation and breathing concerns with opioid exposure. Older adults and people with lung disease, sleep apnoea, kidney impairment, head injury or liver disease need individualized professional review.

Storage and disposal

Keep the medicine in its original labelled container, secured away from children and other people. Do not keep unused tablets for later use; use a pharmacy take-back service or official disposal instructions.

Medicine identity at a glance

Active ingredient Oxycodone hydrochloride 10mg + acetaminophen 325mg
Formulation reference Immediate-release combination tablet
Regulatory context Schedule II controlled substance (United States)
Brand / identity reference Percocet / Endocet (E712 imprint reference)
Important safety information: Many medicines described here are controlled or can cause serious harm. Keep them away from children and unauthorized users, avoid unapproved combinations, and use only medicine supplied by a licensed pharmacy under a valid prescription.
Patient information

Percocet E712: medicine information and safety overview

At a glance

Percocet E712 is described in the reference guide as an immediate-release combination containing oxycodone hydrochloride 10mg and acetaminophen 325mg. The E712 imprint is associated with the 10/325 strength of Endocet; a tablet marking does not independently verify authenticity.

This guide page summarizes the supplied medicine-reference chapter. It is not a personalized recommendation, a product-authentication service, or a substitute for the official package leaflet. The exact formulation and manufacturer's authorization should be checked for the product actually dispensed.

Further reading and source references

These links are starting points for official or patient-facing information. Always check the leaflet and label for the precise product, manufacturer and jurisdiction.

Frequently asked questions

The guide describes oxycodone hydrochloride 10mg and acetaminophen 325mg in an immediate-release tablet.

The guide associates E712 with the Endocet 10/325 strength. Imprints alone do not authenticate a tablet.

Respiratory depression, opioid misuse and dependence, dangerous sedative interactions, and acetaminophen-related liver injury.

The reference warns that alcohol increases sedation and respiratory risk and can worsen acetaminophen-related liver injury.

?